Atopic Dermatitis
Latest News
BREEZE-AD-PEDS: First data for baricitinib in childhood eczema reported
Treatment with the oral JAK inhibitor was significantly more effective than placebo only with the highest dose evaluated.
Latest News
Study identifies skin biomarkers that predict newborn eczema risk
"We are able to identify predictive immune biomarkers of atopic dermatitis using a noninvasive method," the investigator said.
Latest News
Early emollient use reduces dermatitis in at-risk infants
Daily emollient use was associated with a 29% lower risk of cumulative AD at 1 year in comparison with the control intervention.
Latest News
Tralokinumab earns EU recommendation to expand age range for atopic dermatitis to include adolescents
In December 2021, tralokinumab was approved for adults with moderate to severe AD in the United States, where it is marketed as Adbry.
Latest News
Roflumilast foam effectively eases seborrheic dermatitis
The study evaluated a foam formulation of roflumilast, a PDE4 inhibitor that is available for topical use in a cream formulation that was recently...
Latest News
VTE risk not elevated in AD patients on JAK inhibitors: Study
The labels of JAK inhibitors include a boxed warning describing an increased risk of “serious heart-related events such as heart attack or stroke...
Latest News
Vitamin D supplements during pregnancy may protect infants from atopic eczema
“Our data provide the first randomized controlled trial evidence of a protective effect of antenatal cholecalciferol supplementation on risk of...
Conference Coverage
Topical ruxolitinib quickly relieves atopic dermatitis itch in Black patients
Ruxolitinib cream provides quick itch relief for Black patients with atopic dermatitis, researchers report.
Conference Coverage
Cultural humility required to optimize treatment of eczema patients with skin of color
Treating eczema in patients with skin of color requires cultural lens.
Latest News
Eczema causes substantial burden for many infants and preschoolers
INDIANAPOLIS –
From the Journals
Antibiotics during pregnancy may increase child’s risk for asthma and other atopic diseases
“It is estimated that 20%-25% of pregnant women receive at least one course of an antibiotic during this time period.”